Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis

Published:2013-08-02 Issue:1 Volume:14 Page:
ISSN:1471-2474
Container-title:BMC Musculoskeletal Disorders
language:en
Short-container-title:BMC Musculoskelet Disord

Author:

Andersson Maria L E,Svensson Björn,Petersson Ingemar F,Hafström Ingiäld,Albertsson Kristina,Forslind Kristina,Heinegård Dick,Saxne Tore

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1186/1471-2474-14-229.pdf

Reference46 articles.

1. Katchamart W, Johnson S, Lin HJ, Phumethum V, Salliot C, Bombardier C: Predictors for remission in rheumatoid arthritis patients: A systematic review. Arthritis Care Res (Hoboken). 2010, 62: 1128-1143. 10.1002/acr.20188.

2. Scott DL, Smith C, Kingsley G: Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol. 2003, 21: S20-S27.

3. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL: The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 2001, 44: 2009-2017. 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L.

4. Wick MC, Lindblad S, Klareskog L, Van Vollenhoven RF: Relationship between inflammation and joint destruction in early rheumatoid arthritis: a mathematical description. Ann Rheum Dis. 2004, 63: 848-852. 10.1136/ard.2003.015172.

5. Pincus T, Sokka T: Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am. 2009, 35: 731-734. 10.1016/j.rdc.2009.10.007. vi-vii

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity;BMC Rheumatology;2023-12-01

2. Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis;Journal of Clinical Medicine;2023-08-09

3. Anti‐rheumatoid arthritis effects of Xanthii Fructus by affecting the PI3K‐AKT signaling pathway based on TMT‐labeled quantitative proteomics;Biomedical Chromatography;2022-10-24

4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types;Clinical and Translational Oncology;2022-10-18

5. Cartilage Oligomeric Matrix Protein, Diseases, and Therapeutic Opportunities;International Journal of Molecular Sciences;2022-08-17